Search

The article discusses the role of the Holocaust in Israeli history and its impact on the Israeli-Palestinian conflict. It argues that the Holocaust has been used as a justification for the occupation and oppression of Palestinians, and that Israeli leaders have cultivated a mentality of self-victimization and self-righteousness. The article also criticizes the misuse of terminology, such as labeling criticism of Israeli policies as antisemitism, and calls for clarity and purpose in resolving the conflict through non-violent means and international intervention. The author emphasizes the need for peace, justice, and dignity for all people in the region. [Extracted from the article]

There have been significant advances in the treatment of hepatobiliary cancers, especially for advanced-stage disease. However, data is limited for optimal therapy selection in the first line and sequencing of available options. This review covers the systemic treatment of hepatobiliary cancers with an emphasis on the advanced stage. The previously published and ongoing trials will be discussed to create an algorithm for the current practice and to give future perspectives on how the field could go forward. While there is no standard-of-care option in the adjuvant treatment of hepatocellular cancer, capecitabine is the standard of care for biliary tract cancer. The efficacy of adjuvant gemcitabine and cisplatin and the added benefit of radiotherapy to chemotherapy are yet to be defined. For the advanced stage, immunotherapy-based combinations became the standard of care for both hepatocellular and biliary tract cancers. The molecularly targeted therapy has profoundly changed the second-line and later treatment for biliary tract cancers, while the optimal second-line treatment for advanced hepatocellular cancer is yet to be defined due to rapid advances in the first-line setting. [ABSTRACT FROM AUTHOR]